Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

1.

A novel role of the checkpoint kinase ATR in leptin signaling.

Ericson E, Wennberg Huldt C, Strömstedt M, Brodin P.

Mol Cell Endocrinol. 2015 Sep 5;412:257-64. doi: 10.1016/j.mce.2015.04.034. Epub 2015 May 14.

2.

Preventive care delivered within Public Dental Service after caries risk assessment of young adults.

Hänsel Petersson G, Ericson E, Twetman S.

Int J Dent Hyg. 2015 Feb 26. doi: 10.1111/idh.12135. [Epub ahead of print]

PMID:
25727487
3.

Caries risk assessment in young adults: A 3-year validation of clinical guidelines used in Public Dental Service.

Hänsel Petersson G, Ericson E, Isberg PE, Twetman S.

Acta Odontol Scand. 2013 Nov;71(6):1645-50. doi: 10.3109/00016357.2013.788734. Epub 2013 Jul 9.

PMID:
23834530
4.

Caries risk assessment in young adults using Public Dental Service guidelines and the Cariogram--a comparative study.

Petersson GH, Ericson E, Isberg PE, Twetman S.

Acta Odontol Scand. 2013 May-Jul;71(3-4):534-40. doi: 10.3109/00016357.2012.696696. Epub 2012 Jul 2.

PMID:
22746223
5.

Clinical comparison of the Bactec Mycosis IC/F, BacT/Alert FA, and BacT/Alert FN blood culture vials for the detection of candidemia.

Ericson EL, Klingspor L, Ullberg M, Ozenci V.

Diagn Microbiol Infect Dis. 2012 Jun;73(2):153-6. doi: 10.1016/j.diagmicrobio.2012.02.020. Epub 2012 Apr 10.

PMID:
22494558
6.

Aphasic status epilepticus: electroclinical correlation.

Ericson EJ, Gerard EE, Macken MP, Schuele SU.

Epilepsia. 2011 Aug;52(8):1452-8. doi: 10.1111/j.1528-1167.2011.03084.x. Epub 2011 May 31.

PMID:
21627646
7.

A comprehensive platform for highly multiplexed mammalian functional genetic screens.

Ketela T, Heisler LE, Brown KR, Ammar R, Kasimer D, Surendra A, Ericson E, Blakely K, Karamboulas D, Smith AM, Durbic T, Arnoldo A, Cheung-Ong K, Koh JL, Gopal S, Cowley GS, Yang X, Grenier JK, Giaever G, Root DE, Moffat J, Nislow C.

BMC Genomics. 2011 May 6;12:213. doi: 10.1186/1471-2164-12-213.

8.

Exploring gene function and drug action using chemogenomic dosage assays.

Ericson E, Hoon S, St Onge RP, Giaever G, Nislow C.

Methods Enzymol. 2010;470:233-55. doi: 10.1016/S0076-6879(10)70010-0. Epub 2010 Mar 1.

PMID:
20946813
9.

Systematic analysis of genome-wide fitness data in yeast reveals novel gene function and drug action.

Hillenmeyer ME, Ericson E, Davis RW, Nislow C, Koller D, Giaever G.

Genome Biol. 2010;11(3):R30. doi: 10.1186/gb-2010-11-3-r30. Epub 2010 Mar 12.

10.

Chemical-genetic profiling of imidazo[1,2-a]pyridines and -pyrimidines reveals target pathways conserved between yeast and human cells.

Yu L, Lopez A, Anaflous A, El Bali B, Hamal A, Ericson E, Heisler LE, McQuibban A, Giaever G, Nislow C, Boone C, Brown GW, Bellaoui M.

PLoS Genet. 2008 Nov;4(11):e1000284. doi: 10.1371/journal.pgen.1000284. Epub 2008 Nov 28.

11.

Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model.

Ereth MH, Schaff M, Ericson EF, Wetjen NM, Nuttall GA, Oliver WC Jr.

Neurosurgery. 2008 Oct;63(4 Suppl 2):369-72; discussion 372. doi: 10.1227/01.NEU.0000327031.98098.DD.

PMID:
18981845
12.

Off-target effects of psychoactive drugs revealed by genome-wide assays in yeast.

Ericson E, Gebbia M, Heisler LE, Wildenhain J, Tyers M, Giaever G, Nislow C.

PLoS Genet. 2008 Aug 8;4(8):e1000151. doi: 10.1371/journal.pgen.1000151.

13.

PROPHECY--a yeast phenome database, update 2006.

Fernandez-Ricaud L, Warringer J, Ericson E, Glaab K, Davidsson P, Nilsson F, Kemp GJ, Nerman O, Blomberg A.

Nucleic Acids Res. 2007 Jan;35(Database issue):D463-7. Epub 2006 Dec 5.

14.

In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.

Fraenkel CJ, Ullberg M, Bernander S, Ericson E, Larsson P, Rydberg J, Törnqvist E, Melhus A.

Scand J Infect Dis. 2006;38(10):853-9.

PMID:
17008228
15.

Genetic pleiotropy in Saccharomyces cerevisiae quantified by high-resolution phenotypic profiling.

Ericson E, Pylvänäinen I, Fernandez-Ricaud L, Nerman O, Warringer J, Blomberg A.

Mol Genet Genomics. 2006 Jun;275(6):605-14. Epub 2006 Mar 14.

PMID:
16534619
16.

PROPHECY--a database for high-resolution phenomics.

Fernandez-Ricaud L, Warringer J, Ericson E, Pylvänäinen I, Kemp GJ, Nerman O, Blomberg A.

Nucleic Acids Res. 2005 Jan 1;33(Database issue):D369-73.

17.

Potent nonpeptide vasopressin receptor antagonists based on oxazino- and thiazinobenzodiazepine templates.

Matthews JM, Hoekstra WJ, Dyatkin AB, Hecker LR, Hlasta DJ, Poulter BL, Andrade-Gordon P, de Garavilla L, Demarest KT, Ericson E, Gunnet JW, Hageman W, Look R, Moore JB, Reynolds CH, Maryanoff BE.

Bioorg Med Chem Lett. 2004 Jun 7;14(11):2747-52.

PMID:
15125926
18.

High-resolution yeast phenomics resolves different physiological features in the saline response.

Warringer J, Ericson E, Fernandez L, Nerman O, Blomberg A.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15724-9. Epub 2003 Dec 15.

19.

2,5-disubstituted 3,4-dihydro-2H-benzo[b][1,4]thiazepines as potent and selective V2 arginine vasopressin receptor antagonists.

Urbanski MJ, Chen RH, Demarest KT, Gunnet J, Look R, Ericson E, Murray WV, Rybczynski PJ, Zhang X.

Bioorg Med Chem Lett. 2003 Nov 17;13(22):4031-4.

PMID:
14592501
20.

Synthesis and biological evaluation of novel indoloazepine derivatives as non-peptide vasopressin V2 receptor antagonists.

Matthews JM, Greco MN, Hecker LR, Hoekstra WJ, Andrade-Gordon P, de Garavilla L, Demarest KT, Ericson E, Gunnet JW, Hageman W, Look R, Moore JB, Maryanoff BE.

Bioorg Med Chem Lett. 2003 Feb 24;13(4):753-6.

PMID:
12639574
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk